From Surf Wiki (app.surf) — the open knowledge base
Intermenstrual bleeding
Vaginal bleeding at irregular intervals between expected menstrual periods
Vaginal bleeding at irregular intervals between expected menstrual periods
| Field | Value |
|---|---|
| name | Intermenstrual bleeding |
| synonyms | Metrorrhagia, irregular vaginal bleeding |
| field | Gynecology |
| symptoms | Bleeding in between periods |
| risks | Family history |
| diagnosis | Based on physical examination |
| differential | Irregular menstruation |
Intermenstrual bleeding (IMB), or metrorrhagia, is abnormal vaginal bleeding at irregular intervals between expected menstrual periods. It may be associated with bleeding with sexual intercourse. The term metrorrhagia, in which metro means measure and -rrhagia means abnormal flow, is no longer recommended.
In some women, menstrual spotting between periods occurs as a normal and harmless part of ovulation. Some women experience acute mid-cycle abdominal pain around the time of ovulation (sometimes referred to by the German term for this phenomenon, mittelschmerz). This may also occur at the same time as menstrual spotting.
The term breakthrough bleeding (or breakthrough spotting) is usually used for women using hormonal contraceptives, such as IUDs or oral contraceptives. It refers to bleeding or spotting between any expected withdrawal bleeding, or at any time if none is expected. If spotting continues beyond the first 3–4 cycles of oral contraceptive use, a woman should have her prescription adjusted to a pill containing higher estrogen:progesterone ratio by either increasing the estrogen dose or decreasing the relative progesterone dose.
Besides the aforementioned physiologic forms, IMB may also represent abnormal uterine bleeding and be a sign of an underlying disorder, such as a hormone imbalance, endometriosis, uterine fibroids, uterine cancer, or vaginal cancer.
If the bleeding is repeated and heavy, it can cause significant iron-deficiency anemia.
Causes
Intermittent spotting between periods can result from any of numerous reproductive system disorders: Neoplasia:
- Cervical cancer
- Uterine cancer
- Vaginal cancer
- Endometrial cancer
- Primary fallopian tube cancer
- Ovarian cancer
Inflammation:
- Cervicitis
- Endometritis
- Vaginitis
- Sexually Transmitted Infections
- Pelvic inflammatory disease
Endometrial abnormalities:
- Endometriosis
- Adenomyosis
- Uterine leiomyomas
- Endometrial hyperplasia
- Polyps}}
Endocrinological causes:
- Hormone imbalance
- Dysfunctional uterine bleeding
- Diets which induce ketosis, such as the Atkins diet
- polycystic ovarian syndrome}}
Bleeding disorders:
- Von Willebrand Disease
- Pancytopenia due to leukemia
Drug induced:
- Use of progestin-only contraceptives, such as Depo Provera
- Change in oral contraception
- Overdose of anticoagulant medication or Aspirine abuse
Traumatic causes:
- Automutilation
- Sexual abuse or rape
Related to pregnancy:
- Implantation bleeding
- Ectopic pregnancy
- (Incomplete) miscarriage
Other causes:
- Enlarged uterus with menorrhea
Breakthrough bleeding
Breakthrough bleeding (BTB) is any of various forms of vaginal bleeding, usually referring to mid-cycle bleeding in users of combined oral contraceptives as attributed to insufficient estrogens.Farlex Medical Dictionary Breakthrough Bleeding, in turn citing:
- Segen's Medical Dictionary. Copyright 2012
- McGraw-Hill Concise Dictionary of Modern Medicine. Copyright 2002 It may also occur with other hormonal contraceptives. Sometimes, breakthrough bleeding is classified as abnormal and thereby as a form of IMB.
In the context of hemophilia, the term describes a bleeding that occurs while a patient is on prophylaxis.
Presentation
The bleeding is usually light, often referred to as "spotting," though a few people may experience heavier bleeding.
It is estimated that breakthrough bleeding affects around 25% of combined oral contraceptive pill (COCP) users during the initial 3 to 4 months of use, it then usually resolves on its own.
Mechanism
Breakthrough bleeding is commonly due to 4 factors: physiologic effects of OCs on the endometrium, OC-related parameters, (dose, formulation, and regimen), patient behavior, (compliance, using concomitant medications, and smoking) and benign or malignant pathology.
Treatment
Breakthrough bleeding that does not resolve on its own is a common reason for women to switch to different pill formulations, or to switch to a non-hormonal method of birth control.
References
References
- (June 2017). "Abnormal Uterine Bleeding: Current Classification and Clinical Management.". Obstetrics and Gynecology Clinics of North America.
- (2023). "Netter's Obstetrics and Gynecology: Netter's Obstetrics and Gynecology". Elsevier.
- "Rrhagia | Define Rrhagia at Dictionary.com". Dictionary.reference.com.
- (2004). "The New Harvard Guide to Women's Health". Harvard University Press.
- [http://www.merriam-webster.com/medical/breakthrough%20bleeding Merriam-Webster's Medical Dictionary > Breakthrough bleeding] Retrieved on Feb 28, 2010
- "Prophylaxis: Barriers and challenges – World Federation of Hemophilia".
- (2012). "Iatrogenic unscheduled (breakthrough) endometrial bleeding". Rev Endocr Metab Disord.
- (2006). "Oral contraceptives and breakthrough bleeding: What patients need to know". The Journal of Family Practice.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Intermenstrual bleeding — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report